The National Health Insurance Corporation said on November 11 that it finally agreed with MSD Korea to get Januvia (sitagliptin phosphate) listed in the national health insurance.
Under the agreement, Januvia 100 mg is valued at 1,020 won per tablet. The drug strengths include 25 mg, 50 mg and 100 mg.
Januvia is an oral antihyperglycemic of the dipeptidyl-peptidase-4 (DPP-4) inhibitor cla...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.